Buserelin

Also known as [D-Ser(tBu)6,des-Gly10]-GnRH ethylamide

A modified GnRH nonapeptide used to study receptor signalling, pituitary gonadotroph responses and sustained-stimulation desensitisation.

Length: 9 amino acids
Half-life: Not well characterised
Mechanism: Buserelin activates the gonadotrophin-releasing hormone receptor (GnRHR), principally engaging Gq/11-dependent phospholipase C signalling and intracellular calcium mobilisation. Sustained receptor stimulation can produce desensitisation and altered gonadotrophin synthesis and secretion in experimental pituitary systems.
Studied in: Pituitary cell cultures, recombinant GnRHR assays and rodent endocrine models use buserelin to investigate receptor activation, stimulus timing and gonadotroph feedback.

About Buserelin

Buserelin is a synthetic analogue of gonadotrophin-releasing hormone, the hypothalamic decapeptide identified through peptide isolation and sequencing work in the early 1970s. Its structure retains the N-terminal pyroglutamate and central recognition sequence of GnRH but replaces glycine at position 6 with O-tert-butyl-D-serine. The terminal glycinamide is removed, and proline at position 9 carries an ethylamide group, giving a nine-residue peptide with modifications that increase resistance to enzymatic cleavage.

At pituitary GnRH receptors, buserelin links receptor occupancy to phosphoinositide turnover, calcium mobilisation and gonadotrophin release. Experimental responses depend strongly on exposure pattern: brief stimulation and sustained stimulation do not produce equivalent cellular states. Researchers therefore use this analogue to examine receptor responsiveness, gonadotroph gene expression and feedback within reproductive endocrine models. Receptor species, culture conditions and the time selected for measurement can substantially influence the apparent activity recorded in an assay.

Laboratory notes

Confirm peptide identity, purity and counterion from the batch documentation; acetate content and residual water affect peptide-equivalent concentration.
Use single-use aliquots where stability permits, and validate recovery from assay vessels at low concentrations because surface adsorption can distort results.
Distinguish acute calcium or inositol phosphate measurements from longer-term desensitisation assays; document stimulation duration and washout conditions.

Storage and reconstitution basics: storage guide.

Questions about Buserelin

Why is buserelin described as a nonapeptide?

It lacks the tenth glycine residue of native GnRH. Its ninth residue, proline, terminates in an ethylamide rather than continuing to glycinamide.

What does D-Ser(tBu) mean?

It denotes D-serine with a tert-butyl group on the side-chain oxygen. This position-6 substitution changes local conformation and proteolytic susceptibility.

Is reduced signalling after sustained exposure evidence of antagonism?

Not by itself. Buserelin is an agonist, but sustained stimulation can reduce subsequent responsiveness through cellular desensitisation and downstream adaptation.

Is Buserelin for human use?

No. It is supplied strictly for in-vitro laboratory research and is not for human or animal consumption.

Related research peptides

All products are sold for laboratory research use only. Not for human consumption, not a medicine, not for diagnosing, treating or preventing any condition.